Multiple Sclerosis News Today9h
Expanded access program doses 4 new patients with nasal foralumab
Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded access program.
Elixirgen Therapeutics Granted FDA Orphan Drug Designation for EXG-34217 for Treatment of Telomere Biology Disorders
The FDA recently granted EXG-34217 Rare Pediatric Disease Designation (RPDD) and Regenerative Medicine Advanced Therapy (RMAT) Designation.
Science Daily12h
Big birds like emus are technical innovators, study shows
Large birds -- our closest relations to dinosaurs -- are capable of technical innovation, by solving a physical task to gain access to food.
NanoNewron and its Research to Advance the Treatment of Alzheimer’s Disease are Featured by Rutgers University Newsletters and on Rutgers Today
The article highlights the potentially game-changing approach of the Company towards treating Alzheimer’s Disease, based on technology developed at Rutgers by Dr. Luciano D’Adamio, PhD, MD, New Jersey ...
Food Allergy Research & Education16h
Food Allergy Nonprofit, FARE Announces ATANIS Biotech AG as the Winner of Phase 2 of its Innovation Award Diagnostic Challenge
The FARE Innovation Award Diagnostic Challenge is made possible through generous support from the Naddisy Foundation, the ...
NJBIZ2d
Forbes ranks 31 NJ companies among America’s Best Employers (updated)
To determine the findings, the publication surveyed more than 217,000 employees and asked if they would recommend their ...
NJBIZ2d
Forbes ranks 21 NJ companies among America’s Best Employers
To determine the findings, the publication surveyed more than 217,000 employees and asked if they would recommend their company as well as to rate their firm based on criteria including salary, work ...
What’s a ‘biosolution’? A look at the enzymes and microbes transforming 30 industries
The good news is biosolutions can help. Biosolutions – biological technologies that use enzymes, microbes and functional ...